Suven Life Sciences Rise After Securing Product Patents – Shares of the biopharmaceutical company extended gains for the second day and rose as much as 3.3 percent to Rs 175.30. The company secured product patents in Norway, South Korea and Singapore, used for the treatment of disorders associated with Neurodegenerative diseases.
Suven Life trades at 25.4 times trailing 12-month earnings per share and 21 times its estimates for the coming year. The stock declined 14 percent so far this year and advanced 6.6 percent in the past 52 weeks.
